Clinical Trials Directory

Trials / Terminated

TerminatedNCT04881253

COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)

Status
Terminated
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
Centre Hospitalier Intercommunal Creteil · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this research is to build a collection of non-invasive retinal imaging (OCT and OCTA) in order to investigate the incidence and impact of retinal damage in patients who have or have had COVID-19.

Detailed description

This monocentric study is aimed at 3 types of patients: * Those who have been hospitalized for Covid-19 during the epidemic * Newly infected and diagnosed patients Covid-19 * Those with paucisymptomatic Covid-19 who did not require hospitalisation At the patient's inclusion, an ophthalmologic assessment will be performed including : * visual acuity, * SD-OCT + multicolor, * OCT-A, * color retinography, Fundus examination, optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA) in all COVID-19 patients may detect retinal lesions. In addition, if a correlation is demonstrated between clinical and paraclinical parameters and between disease severity and retinal vascular damage in non-invasive imaging (OCT and OCTA), this would allow a better understanding of the pathophysiology of the disease, as well as factors that may influence disease severity and the mechanisms potentially responsible for the observed disorders.

Conditions

Timeline

Start date
2021-11-05
Primary completion
2023-01-17
Completion
2023-01-17
First posted
2021-05-11
Last updated
2025-09-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04881253. Inclusion in this directory is not an endorsement.